Canadian Cancer Trials Group Bulletins


Recent Publications

There were two recent publications -- one related to Canadian Cancer Trials Group BR.24, and the other related to Canadian Cancer Trials Group LY.7:

Goodwin R, Ding K, Seymour L, Le Maître A, Arnold A, Shepherd FA, Dediu M, Ciuleanu T, Fenton D, Zukin M, Walde D, Laberge F, Vincent M, Ellis PM, Laurie SA. Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: Canadian Cancer Trials Group study BR24 (ONLINE). Ann Oncol 2010.

van Oers MHJ, van Glabbeke M, Giurgea L, Klasa R, Marcus RE, Wolf M, Kimby E, van't Veer M, Vranovsky A, Holte H, Hagenbeek A. Rituximab maintenance treatment relapsed/resistant follicular non-Hodgkin lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study (ONLINE). J Clin Oncol 2010.